REMS & Preemption. E&C Redemption?

CongressNow reports that,

“House Democrats relented and removed two of the most controversial provisions from pending Food and Drug Administration legislation, withdrawing language overturning federal preemption and a requirement for mandatory post-market reviews, Congressional and other sources say.”

According to an aide to Rep. Michael Burgess (R-Texas), the preemption language and a provision for mandatory risk evaluation and mitigation strategies “have been dropped.”

More as more develops.